Fujita, Kenji P.
https://orcid.org/0000-0003-4320-7557
Mayo Clinic
Alnylam Pharmaceuticals (United States)
Citations 5
12-Month Analysis of ILLUMINATE-A, a Phase 3 Study of Lumasiran: Sustained Oxalate Lowering and Kidney Stone Event Rates in Primary Hyperoxaluria Type 1
Saland, Jeffrey M. , Groothoff, Jaap W. , Frishberg, Yaacov, Hulton, Sally A., Koren, Michael J. , Overcash, Jeffrey S., Sellier-Leclerc, Anne-Laure A., Shasha‐Lavsky, Hadas , Magen, Daniella , Moochhala, Shabbir H. , Šimková, Eva, Sas, David J. , Meliambro, Kristin, Ngo, Taylor , Fujita, Kenji P. , Gansner, John M. , McGregor, Tracy L., Sellier‐Leclerc, Anne‐Laure , Deschênes, Georges , Hayes, Wesley Nathan , Fuster, Daniel Guido , Coenen, Martin , Garrelfs, Sander F. , Lieske, John C.
Journal of the American Society of Nephrology | May 17, 2024 | Volume: 31 | Issue: 10S | Pages: B8-B8
ILLUMINATE-B, a Phase 3 Open-Label Study to Evaluate Lumasiran, an RNAi Therapeutic, in Young Children with Primary Hyperoxaluria Type 1 (PH1)
Michael, Mini , Cochat, Pierre , Magen, Daniella , Hoff, William van’t , Sas, David J. , Schalk, Gesa, Shasha‐Lavsky, Hadas , Bae, Kyounghwa, Seddighzadeh, Ali, Garg, Pushkal, Vaishnaw, Akshay, McGregor, Tracy L., Fujita, Kenji P. , Frishberg, Yaacov, Deschênes, Georges , Hayes, Wesley Nathan
Journal of the American Society of Nephrology | May 17, 2024 | Volume: 31 | Issue: 10S | Pages: 515-515
Impact of Eculizumab on Hospitalization Rates and Relapse Treatment in Patients with Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder: the Phase 3 PREVENT Study (1780)
Kim, Ho Jin , Palace, Jacqueline , Terzi, Murat , Wang, Kaichen , Pace, Amy, Fujita, Kenji P. , Yountz, Marcus, Armstrong, Róisín, Wingerchuk, Dean M. , Palace, Jacqueline , Palace, Jacqueline , Pittock, Sean J. , Berthele, Achim , Fujihara, Kazuo , Levy, Michael , Nakashima, Ichiro , Totolyan, N. А. , Viswanathan, Shanthi
Neurology | December 7, 2023 | Volume: 94 | Issue: 15_supplement | Pages: No page available
Long-term Safety and Efficacy of Eculizumab in Neuromyelitis Optica Spectrum Disorder (1494)
Wingerchuk, Dean M. , Kim, Ho Jin , Palace, Jacqueline , Terzi, Murat , Wang, Kaichen , Allen, Kerstin , Fujita, Kenji P. , Yountz, Marcus, Armstrong, Róisín, Palace, Jacqueline , Pittock, Sean J. , Berthele, Achim , Fujihara, Kazuo , Levy, Michael , Nakashima, Ichiro , Totolyan, N. А. , Viswanathan, Shanthi
Neurology | December 7, 2023 | Volume: 94 | Issue: 15_supplement | Pages: No page available
Eculizumab in Aquaporin-4–Positive Neuromyelitis Optica Spectrum Disorder
Pittock, Sean J. , Kim, Ho Jin , Levy, Michael , Palace, Jacqueline , Terzi, Murat , Totolyan, N. А. , Wang, Kaichen , Pace, Amy , Fujita, Kenji P. , Armstrong, Róisín, Wingerchuk, Dean M. , Nakashima, Ichiro , Totolyan, Natalia, Viswanathan, Shanthi , Wang, Kai‐Chen , Pittock, S J , Levy, Michael , Berthele, Achim , Fujihara, Kazuo , Palace, Jacqueline
New England Journal of Medicine | May 3, 2019 | Volume: 381 | Issue: 7 | Pages: 614-625